Vericel
VCEL
57.52
-0.74
-1.27%
Vericel
US · VCEL
#2759 by market cap
Listed 1970
57.52
-0.74
-1.27%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 3 in the most recent period (2026/Q3).
- Total institutional ownership fell 1.5 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 109.60% -1.47pp
- Institutions
- 389 +3
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund90.70%
Hedge Fund10.12%
Public Company4.54%
Government Pension Fund1.71%
Insurance Company1.33%
Individual/Insider1.20%
Private Company0.82%
Sovereign Wealth Fund0.19%
Family Office/Trust0.13%
Top holders as of 2026-09-30
BlackRock
16.00% · 8.17M sh
State Street Global Advisors
6.28% · 3.20M sh
Congress Asset Management Company, LLP
5.00% · 2.55M sh
Vanguard Capital Management, LLC
4.43% · 2.26M sh
William Blair Investment Management, LLC
3.84% · 1.96M sh
BNPP Asset Management Holding
3.21% · 1.64M sh
Conestoga Capital Advisors, LLC
3.08% · 1.57M sh
GW&K Investment Management, LLC
3.01% · 1.54M sh
Soleus Capital Management, L.P.
2.86% · 1.46M sh
Geode Capital Management, LLC
2.74% · 1.40M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 19 buys · 31 sells
| Name | Role | Stake |
|---|---|---|
| Dominick Colangelo | Chief Executive Officer | 0.61% |
| Jonathan Hopper | Chief Medical Officer | 0.15% |
| Alan Rubino | Independent Director | 0.13% |
| Heidi Hagen | Independent Director | 0.07% |
| Robert Zerbe | Independent Chairperson | 0.06% |
| Paul Wotton | Independent Director | 0.04% |
| Kevin McLaughlin | Independent Director | 0.04% |
| Michael Halpin | Chief Operating Officer | 0.03% |
| Joseph Mara | Chief Financial Officer | 0.03% |
| Lisa Wright | Independent Director | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-12 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Intent to Sell (Form 144) | -1,885 | $57.71 |
| 2026-11-10 | Joseph Mara | Chief Financial Officer | Derivative Exercise and Sale | -25,008 | $43.63–59.75 |
| 2026-11-10 | Joseph Mara | Chief Financial Officer | Other Derivative Acquisition | +25,008 | $43.63 |
| 2026-11-10 | Joseph Mara | Chief Financial Officer | Intent to Sell (Form 144) | -8 | $59.75 |
| 2026-11-09 | Kevin McLaughlin | Independent Director | Derivative Exercise and Sale | -7,000 | $13.05–58.96 |
| 2026-11-09 | Kevin McLaughlin | Independent Director | Other Derivative Acquisition | +7,000 | $13.05 |
| 2026-11-08 | Robert Zerbe | Independent Chairperson | Derivative Exercise and Sale | -2,000 | $13.05–57.88 |
| 2026-11-08 | Robert Zerbe | Independent Chairperson | Other Derivative Acquisition | +2,000 | $13.05 |
| 2026-11-08 | Joseph Mara | Chief Financial Officer | Intent to Sell (Form 144) | -25,000 | $58.26 |
| 2026-11-05 | Joseph Mara | Chief Financial Officer | Other Derivative Acquisition | +50,000 | $29.82–34.90 |
| 2026-11-05 | Joseph Mara | Chief Financial Officer | Intent to Sell (Form 144) | -28,641 | $53.42 |
| 2026-11-05 | Joseph Mara | Chief Financial Officer | Derivative Exercise and Sale | -28,641 | $29.82–53.43 |
| 2026-11-04 | Robert Zerbe | Independent Chairperson | Derivative Exercise and Sale | -5,500 | $13.05–55.00 |
| 2026-11-04 | Robert Zerbe | Independent Chairperson | Intent to Sell (Form 144) | -3,000 | $52.23 |
| 2026-11-04 | Sean Flynn | Chief Legal Officer | Derivative Exercise and Sale | -15,000 | $16.25–51.92 |
| 2026-11-04 | Joseph Mara | Chief Financial Officer | Other Acquisition | +21,359 | $29.82–34.90 |
| 2026-11-04 | Joseph Mara | Chief Financial Officer | Open Market Disposition | -21,359 | $53.40–53.73 |
| 2026-11-04 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Derivative Exercise and Sale | -1,500 | $34.90–52.90 |
| 2026-11-03 | Robert Zerbe | Independent Chairperson | Intent to Sell (Form 144) | -2,500 | $45.40 |
| 2026-08-11 | Kevin McLaughlin | Independent Director | Derivative Exercise and Sale | -7,000 | $13.05–44.53 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Vericel discussion 0 comments